<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://edxmedical.co.uk/wp-content/plugins/thinkrank/static/xsl/sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1">
	<url>
		<loc>https://edxmedical.co.uk/watch-edx-medical-presents-progress-on-diagnostics-and-corporate-health-screening/</loc>
		<video:video>
			<video:thumbnail_loc>https://img.youtube.com/vi/_aRj6saMrnw/hqdefault.jpg</video:thumbnail_loc>
			<video:title>Watch: EDX Medical presents progress on diagnostics and corporate health screening</video:title>
			<video:description>EDX Medical’s latest investor presentation is now available to watch, with founder and Chief Scientific Officer Professor Sir Chris Evans outlining the company’s progress in bringing advanced diagnostic tests and services to market. Hosted by Investor Meet Company on 14 October 2026, the presentatio</video:description>
			<video:player_loc>https://www.youtube.com/embed/_aRj6saMrnw</video:player_loc>
			<video:publication_date>2026-10-15T10:14:25+00:00</video:publication_date>
		</video:video>
	</url>
	<url>
		<loc>https://edxmedical.co.uk/vox-markets-interviews-prof-sir-chris-evans-about-edx-medicals-growth-plans/</loc>
		<video:video>
			<video:thumbnail_loc>https://img.youtube.com/vi/-WLWgd3tAj0/hqdefault.jpg</video:thumbnail_loc>
			<video:title>Vox Markets interviews Prof. Sir Chris Evans about EDX Medical’s growth plans</video:title>
			<video:description>EDX Medical founder Professor Sir Chris Evans has discussed the company’s growing portfolio of cancer and precision-diagnostic tests in an interview with Vox Markets. The interview covers the recently launched BC95 bowel-cancer service and EDX Medical’s plans to expand into employee health screening</video:description>
			<video:player_loc>https://www.youtube.com/embed/-WLWgd3tAj0</video:player_loc>
			<video:publication_date>2026-07-30T09:57:36+00:00</video:publication_date>
		</video:video>
	</url>
	<url>
		<loc>https://edxmedical.co.uk/employee-screening-service-explained-by-sir-chris-evans-in-new-directorstalks-interview/</loc>
		<video:video>
			<video:thumbnail_loc>https://vumbnail.com/1210445501.jpg</video:thumbnail_loc>
			<video:title>Employee screening service explained by Sir Chris Evans in new DirectorsTalks Interview</video:title>
			<video:description>EDX Medical founder and chief scientific officer Sir Chris Evans has explained in a new interview why he believes the Company&apos;s new workplace health screening service can generate more than £2 million in the current financial year, with employers already discussing programmes covering thousands of s</video:description>
			<video:player_loc>https://player.vimeo.com/video/1210445501</video:player_loc>
			<video:publication_date>2026-07-17T10:42:49+00:00</video:publication_date>
		</video:video>
	</url>
	<url>
		<loc>https://edxmedical.co.uk/professor-chris-evans-discusses-edx-medicals-growth-ambitions-in-new-london-south-east-interview/</loc>
		<video:video>
			<video:thumbnail_loc>https://img.youtube.com/vi/B4hABMyp_xQ/hqdefault.jpg</video:thumbnail_loc>
			<video:title>Professor Chris Evans discusses EDX Medical’s growth ambitions in new London South East interview</video:title>
			<video:description>Professor Sir Chris Evans, Founder and Chief Scientific Officer of EDX Medical, has taken part in a new interview with London South East’s Focus IR, discussing the company’s ambition to become a leading international player in precision cancer diagnostics. The interview explores EDX Medical’s next p</video:description>
			<video:player_loc>https://www.youtube.com/embed/B4hABMyp_xQ</video:player_loc>
			<video:publication_date>2026-05-19T16:52:21+00:00</video:publication_date>
		</video:video>
	</url>
	<url>
		<loc>https://edxmedical.co.uk/founder-cso-sir-chris-evans-interviewed-by-director-talks-interviews/</loc>
		<video:video>
			<video:thumbnail_loc>https://vumbnail.com/1191617045.jpg</video:thumbnail_loc>
			<video:title>Founder &amp; CSO Sir Chris Evans interviewed by DirectorsTalks Interviews</video:title>
			<video:description>Cancer diagnostics are moving beyond broad screening and into precision-led detection, and EDX Medical founder and chief scientific officer Sir Chris Evans believes the company is positioned at the centre of that transition. Speaking to DirectorsTalks Interviews on the day EDX Medical&apos;s shares were </video:description>
			<video:player_loc>https://player.vimeo.com/video/1191617045</video:player_loc>
			<video:publication_date>2026-05-13T09:24:10+00:00</video:publication_date>
		</video:video>
	</url>
	<url>
		<loc>https://edxmedical.co.uk/uk-parliament-health-committee-examines-innovation-needed-to-improve-cancer-outcomes/</loc>
		<video:video>
			<video:thumbnail_loc>https://img.youtube.com/vi/BndZn1PgxsU/hqdefault.jpg</video:thumbnail_loc>
			<video:title>UK Parliament Health Committee examines innovation needed to improve cancer outcomes</video:title>
			<video:description>As part of its Future Cancer Inquiry, the UK Parliament’s Health &amp;amp; Social Care Select Committee ( Future cancer - Committees - UK Parliament) has taken oral evidence this week from experts to establish the extent to which innovation can improve outcomes for some of the least survivable cancers, </video:description>
			<video:player_loc>https://www.youtube.com/embed/BndZn1PgxsU</video:player_loc>
			<video:publication_date>2024-01-12T14:56:45+00:00</video:publication_date>
		</video:video>
	</url>
</urlset>